Givinostat, Vamorolone significant for Georgian health system - Health Minister
Georgian Health Minister Mikheil Sarjveladze views the introduction of two new medicines, Givinostat and Vamorolone, for the treatment of Duchenne muscular dystrophy (DMD) as significant for the Georgian health system.
“Negotiations on the import of Vamorolone have concluded successfully. Only the exchange of signed copies remains, after which work will proceed intensively to make the medication available to patients,” Mikheil Sarjveladze announced following the government meeting.
At today’s meeting, a decision was made regarding the regulation of logistical matters, namely, who will deliver the medication and through which procedure.
This required regulation through a government decree, which would serve as the basis for subsequently defining all procedures in detail via subordinate normative acts. This also includes medical staff training, prescription and monitoring of its use, and measuring its efficiency. We will continue to work in this direction for the medicine to be most effective for each patient,” he said.
Most Read
Other News
Givinostat, Vamorolone significant for Georgian health system - Health Minister
07.10.2026.18:01
Georgian Health Minister Mikheil Sarjveladze views the introduction of two new medicines, Givinostat and Vamorolone, for the treatment of Duchenne muscular dystrophy (DMD) as significant for the Georgian health system.
“Negotiations on the import of Vamorolone have concluded successfully. Only the exchange of signed copies remains, after which work will proceed intensively to make the medication available to patients,” Mikheil Sarjveladze announced following the government meeting.
At today’s meeting, a decision was made regarding the regulation of logistical matters, namely, who will deliver the medication and through which procedure.
This required regulation through a government decree, which would serve as the basis for subsequently defining all procedures in detail via subordinate normative acts. This also includes medical staff training, prescription and monitoring of its use, and measuring its efficiency. We will continue to work in this direction for the medicine to be most effective for each patient,” he said.
Rehabilitation center for Children with Duchenne Muscular Dystrophy to be built in Tbilisi
16.09.2026.21:26
First shipment of Duchenne muscular dystrophy drug Givinostat to arrive in Georgia next week
04.09.2026.17:07
Health Minister is optimistic that state healthcare programme expansion will yield life-changing benefits
05.08.2026.22:18
Georgia signs agreement with Italian Italfarmaco to procure Givinostat for Duchenne muscular dystrophy patients
31.07.2026.19:53
I was deeply impressed by Health Ministry’s firm resolve to make Givinostat accessible to Georgian patients - Italfarmaco Group CEO
31.07.2026.19:49
Health Minister thanks parents for constructive talks, joint working group critically important to secure DMD medication
04.06.2026.17:52
